VORETIGENE NEPARVOVEC-RZYL

VORETIGENE NEPARVOVEC-RZYL was reported 152 times

These side effects are most commonly reported by patients taking VORETIGENE NEPARVOVEC-RZYL:

# Side effect Count
0 INTRAOCULAR PRESSURE INCREASED 22
1 RETINAL DEGENERATION 15
2 EYE PAIN 12
3 VISUAL IMPAIRMENT 12
4 CATARACT 8
5 CHORIORETINAL ATROPHY 8
6 RETINAL DEPIGMENTATION 8
7 RETINAL TEAR 8
8 OCULAR HYPERAEMIA 7
9 VISION BLURRED 7
10 DRUG INEFFECTIVE 6
11 EYE INFLAMMATION 6
12 OCULAR HYPERTENSION 6
13 BLINDNESS 5
14 DISCOMFORT 5
15 VITREOUS OPACITIES 5
16 CONJUNCTIVAL HAEMORRHAGE 4
17 EYE IRRITATION 4
18 HEADACHE 4
19 MENTAL IMPAIRMENT 4
20 PHOTOPSIA 4
21 CENTRAL VISION LOSS 3
22 FACE OEDEMA 3
23 INTRAOCULAR PRESSURE DECREASED 3
24 OPTIC ATROPHY 3
25 PYREXIA 3
26 SUTURE RELATED COMPLICATION 3
27 VISUAL ACUITY REDUCED 3
28 ANXIETY 2
29 CATARACT SUBCAPSULAR 2
30 CONJUNCTIVAL HYPERAEMIA 2
31 DEPRESSED MOOD 2
32 DISEASE PROGRESSION 2
33 DIZZINESS 2
34 EYE HAEMORRHAGE 2
35 EYE SWELLING 2
36 FOVEAL DEGENERATION 2
37 INTRA-OCULAR INJECTION COMPLICATION 2
38 LENTICULAR OPACITIES 2
39 NIGHT BLINDNESS 2
40 OFF LABEL USE 2
41 PHOTOPHOBIA 2
42 POST PROCEDURAL INFLAMMATION 2
43 PROCEDURAL PAIN 2
44 RASH 2
45 RETINAL DEPOSITS 2
46 RETINAL DETACHMENT 2
47 RHEGMATOGENOUS RETINAL DETACHMENT 2
48 SEIZURE 2
49 VISUAL BRIGHTNESS 2
50 VISUAL FIELD DEFECT 2
51 VITREAL CELLS 2
52 VITREOUS ADHESIONS 2
53 VITREOUS HAEMORRHAGE 2
54 ANOSMIA 1
55 ANTERIOR CHAMBER CELL 1
56 ATRIAL FIBRILLATION 1
57 BALANCE DISORDER 1
58 BLISTER 1
59 BRIEF PSYCHOTIC DISORDER WITH MARKED STRESSORS 1
60 CATARACT OPERATION 1
61 CHILLS 1
62 CHORIORETINAL DISORDER 1
63 CHORIORETINAL FOLDS 1
64 COMPLICATION ASSOCIATED WITH DEVICE 1
65 CONDITION AGGRAVATED 1
66 COUGH 1
67 COVID-19 1
68 DEATH 1
69 DEVICE DISLOCATION 1
70 DISTURBANCE IN ATTENTION 1
71 EAR INFECTION 1
72 EPISCLERITIS 1
73 EYE DISCHARGE 1
74 EYE MOVEMENT DISORDER 1
75 EYE OEDEMA 1
76 EYE PRURITUS 1
77 EYELID INJURY 1
78 EYELID PTOSIS 1
79 FEELING ABNORMAL 1
80 GAIT INABILITY 1
81 GLAUCOMA 1
82 HUMAN HERPESVIRUS 6 INFECTION 1
83 HYPERHIDROSIS 1
84 ILL-DEFINED DISORDER 1
85 INSOMNIA 1
86 IRITIS 1
87 LACRIMATION INCREASED 1
88 LEBER^S CONGENITAL AMAUROSIS 1
89 LOSS OF VISUAL CONTRAST SENSITIVITY 1
90 MENINGIOMA 1
91 METASTASES TO LUNG 1
92 MIGRAINE 1
93 MYOCARDIAL INFARCTION 1
94 NASOPHARYNGITIS 1
95 OCULAR DISCOMFORT 1
96 OROPHARYNGEAL PAIN 1
97 PHARYNGITIS STREPTOCOCCAL 1
98 POST PROCEDURAL DISCOMFORT 1
99 POST PROCEDURAL FEVER 1
100 POSTERIOR CAPSULE OPACIFICATION 1
101 PRODUCT USE ISSUE 1
102 RELAPSING-REMITTING MULTIPLE SCLEROSIS 1
103 RETINAL FOVEA DISORDER 1
104 RETINAL HAEMORRHAGE 1
105 ROSEOLA 1
106 STRABISMUS 1
107 SUSPECTED COVID-19 1
108 SYMPATHETIC OPHTHALMIA 1
109 TESTIS CANCER 1
110 VASCULAR INJURY 1
111 VERTIGO 1
112 VITREOUS FLOATERS 1
113 VITRITIS 1
114 VOGT-KOYANAGI-HARADA DISEASE 1
115 VOMITING 1